Latigo Biotherapeutics, Inc (LTGO) insider trading
Every open-market stock purchase and sale by Latigo Biotherapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- James B. Tananbaum (Insider) and 1 other bought $5M in the last 90 days, growing their stake 7%.
Last 12 months: insiders bought $5M (2 buys) and sold $0 (0 sales). Last close $16.57 on Oct 22, 2026.
Recent LTGO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | James B. Tananbaum (Insider) | Bought | $2.5M |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought | $2.5M |
| Aug 10, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | James B. Tananbaum (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | James B. Tananbaum (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | James B. Tananbaum (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | James B. Tananbaum (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
| Aug 10, 2026 | Foresite Capital Management V LLC (10% owner) | Bought (not open market) | — |
Who's trading LTGO
- Westlake BioPartners Fund I L.P., 10% owner: other filings, last Aug 10, 2026
- Foresite Capital Management V LLC, 10% owner: bought $2.5M (1 buy), last Aug 10, 2026
- Beth C Seidenberg, Insider: other filings, last Aug 10, 2026
- 5AM Ventures VI L.P., Insider: other filings, last Aug 10, 2026
- Sanofi, Insider: other filings, last Aug 10, 2026
- James B. Tananbaum, Insider: bought $2.5M (1 buy), last Aug 10, 2026
- Todd N Smith, Insider: other filings, last Aug 6, 2026
Get free alerts when an insider at Latigo Biotherapeutics, Inc files a new trade →